Tectonic Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$770K Buy
3,633
+26
+0.7% +$5.1K 0.04% 200
2026
Q1
$707K Buy
3,607
+125
+4% +$24.3K 0.04% 200
2025
Q4
$604K Buy
3,482
+162
+5% +$29.5K 0.03% 228
2025
Q3
$633K Sell
3,320
-1
-0% -$177 0.03% 225
2025
Q2
$597K Buy
3,321
+109
+3% +$18.9K 0.03% 225
2025
Q1
$544K Sell
3,212
-162
-5% -$26.6K 0.03% 228
2024
Q4
$509K Buy
3,374
+202
+6% +$31.4K 0.03% 235
2024
Q3
$492K Buy
3,172
+108
+4% +$16.1K 0.03% 241
2024
Q2
$419K Buy
3,064
+266
+10% +$36.4K 0.03% 243
2024
Q1
$372K Buy
2,798
+363
+15% +$47.1K 0.03% 253
2023
Q4
$336K Buy
+2,435
New +$320K 0.03% 244

Other funds holding DGX

Tectonic Advisors's DGX Position: Q2 2026 in Review

Tectonic Advisors increased its Quest Diagnostics (DGX) stake by 0.72% in Q2 2026, buying an estimated $5.1K and bringing the position to 3,633 shares worth $770K. The position accounts for 0.04% of the portfolio, ranked #200.

Tectonic Advisors first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Tectonic Advisors held 3,633 shares of Quest Diagnostics worth $770K as of Q2 2026.
  • Tectonic Advisors bought 26 Quest Diagnostics shares in Q2 2026, an estimated $5.1K.
  • Quest Diagnostics made up 0.04% of Tectonic Advisors's portfolio in Q2 2026, its #200 holding.
  • Tectonic Advisors first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.